Article
Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue
2024-10-05
Abstract excerpt
The NRF2 transcription factor is constitutively active in cancer where it functions to maintain oxidative homeostasis and reprogram cellular metabolism. NRF2-active tumors exhibit NRF2-dependency and resistance to chemo/radiotherapy. Here we characterize VVD-065, a first-in-class NRF2 inhibitor that acts via an unprecedented allosteric molecular glue mechanism. In the absence of stress or mutation, NRF2 is rapidly...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c02f93b9-1515-534e-9e91-c28793d28a8a
- DOI
- 10.1101/2024.10.04.616592
